Clinical Trial Update: Examining the Spasmodic Dysphonia Diagnosis and Assessment Procedure (SD-DAP) for Measuring Symptom Change

View source ↗

Summary

The ClinicalTrials.gov entry for NCT02061943, evaluating the Spasmodic Dysphonia Diagnosis and Assessment Procedure (SD-DAP) to measure symptom change, has been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Laryngeal Dystonia
• Spasmodic Dysphonia

Snippet

Sponsor: Emory University | Conditions: Spasmodic Dysphonia, Laryngeal Dystonia | Status: WITHDRAWN